Shangya Technology Co., Ltd. (TPEX:6130)
Taiwan · Delayed Price · Currency is TWD 23.00
+0.15 (0.66%)
Oct 8, 2026, 1:30 PM CST
Shangya Technology Market Cap
Shangya Technology has a market cap or net worth of 1.06 billion as of October 9, 2026. It is the 33,442nd most valuable company in the world and the 2,023rd biggest in Taiwan. Its market cap has decreased by 40.79% in one year.
Market Cap
1.06B
Enterprise Value
1.09B
Revenue
165.30M
Global Rank
Country Rank
#2,023 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2004, Shangya Technology's market cap has increased from 885.72M to 1.06B, an increase of 20.23%. That is a compound annual growth rate of 0.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.06B | -45.98% |
| Dec 31, 2025 | 1.97B | 88.96% |
| Dec 31, 2024 | 1.04B | -31.54% |
| Dec 29, 2023 | 1.52B | 15.05% |
| Dec 30, 2022 | 1.32B | -7.53% |
| Dec 30, 2021 | 1.43B | 117.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 495.25B |
| Lin BioScience | 142.21B |
| Caliway Biopharmaceuticals | 121.94B |
| Heron Neutron Medical | 83.90B |
| Concord Medical | 1.10B |
| Genetics Generation Advancement | 1.09B |
| Prince Pharmaceutical | 1.06B |
| Rossmax International | 1.06B |